🇺🇸 FDA
Patent

US 8158627

Compositions and treatments using pyridazine compounds and cholinesterase inhibitors

granted A61KA61K31/435A61K31/50

Quick answer

US patent 8158627 (Compositions and treatments using pyridazine compounds and cholinesterase inhibitors) held by Northwestern University expires Mon Apr 12 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Northwestern University
Grant date
Tue Apr 17 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 12 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61K, A61K31/435, A61K31/50, A61K31/501, A61K45/06